Prothena

Why Is Prothena Stock Trading Lower On Tuesday?

May 27, 2025

Prothena Corporation plc (NASDAQ:PRTA) released data from the Phase 3 AFFIRM-AL clinical trial evaluating birtamimab in patients with AL amyloidosis…